Pascuzzi RM, Coslett HB, Johns TR: Long-term corticosteroid treatment of myasthenia gravis: Report of 116 cases. Ann
Neurol 15:291, 1984.
Patrick J, Lindstrom JP: Autoimmune response to acetylcholine receptor. Science 180:871, 1973.
Patrick J, Lindstrom JP, Culp B, McMillan J: Studies on purified eel acetylcholine receptor and antiacetylcholine receptor antibody. Proc Natl Acad Sci U S A 70:3334, 1973.
Pittinger CB, Eryase Y, Adamson R: Antibiotic-induced paralysis. Anesth Analg 49:487, 1970.
Plaster NM, Tawil R, Tristani-Firouzi M, et al: Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen’s syndrome. Cell 105:511, 2001.
Ponseti JM, Azem J, Fort JM, et al: Long-term results of tacrolimus in cyclosporineand prednisone-dependent myasthenia gravis. Neurology 64:1641, 2005.
Poskanzer DC, Kerr DNS: A third type of periodic paralysis with normokalemia and favorable response to NaCl. Am J Med 31:328, 1961.
Price DL, Griffin JW, Peck K: Tetanus toxin: Evidence for binding at presynaptic nerve endings. Brain Res 121:379, 1977.
Ptácek LJ, Tawil R, Griggs RC, et al: Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77:863, 1994a.
Ptácek LJ, Tawil R, Griggs RC, et al: Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis. Neurology 44:1500, 1994b.
Quane KA, Healy JMS, Keating KE, et al: Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat Genet 5:51, 1993.
Rabinstein A, Wijdicks EFM: BiPAP in acute respiratory failure due to myasthenic crisis may prevent intubation. Neurology 59:1647, 2002.
Rakoevic G, Raju R, Semino-Mora C, et al: Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies. Neurology 67:1068, 2006.
Reman L: Zur pathogenese und therapie der myasthenia gravis pseudoparalytica. Dtsch Z Nervenheilkd 128:66, 1932.
Ricker K, Moxley RT, Heine R, Lehmann-Horn F: Myotonia fluctuans: A third type of muscle sodium channel disease. Arch Neurol 51:1095, 1994.
Ricker K, Moxley RT, Rohkamm R: Rippling muscle disease. Arch Neurol 46:405, 1989.
Robertson WC, Chun RWM, Kornguta SE: Familial infantile myasthenia. Arch Neurol 37:117, 1980.
Rodriguez M, Gomez MR, Howard FM: Myasthenia gravis in children: Long-term followup. Ann Neurol 13:504, 1983.